|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_on1265456902 |
003 |
OCoLC |
005 |
20231120010601.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
210828s2022 enk o 000 0 eng d |
040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d OCLCO
|d OCLCF
|d RDF
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCL
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9780323909501
|q (electronic bk.)
|
020 |
|
|
|a 0323909507
|q (electronic bk.)
|
020 |
|
|
|z 0323909493
|
020 |
|
|
|z 9780323909495
|
035 |
|
|
|a (OCoLC)1265456902
|
050 |
|
4 |
|a RC271.I45
|
082 |
0 |
4 |
|a 616.994061
|2 23
|
245 |
0 |
0 |
|a Engineering technologies and clinical translation.
|n Volume 3,
|p Delivery strategies and engineering technologies in cancer immunotherapy /
|c edited by Mansoor M. Amiji, Lara Scheherazade Milane.
|
246 |
3 |
0 |
|a Delivery strategies and engineering technologies in cancer immunotherapy
|
260 |
|
|
|a London :
|b Academic Press,
|c 2022.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
650 |
|
0 |
|a Drug delivery systems.
|
650 |
|
0 |
|a Immunotherapy.
|
650 |
1 |
2 |
|a Neoplasms
|x immunology
|0 (DNLM)D009369Q000276
|
650 |
2 |
2 |
|a Immunotherapy
|0 (DNLM)D007167
|
650 |
2 |
2 |
|a Drug Delivery Systems
|0 (DNLM)D016503
|
650 |
|
6 |
|a Cancer
|x Immunoth�erapie.
|0 (CaQQLa)201-0168739
|
650 |
|
6 |
|a Syst�emes d'administration de m�edicaments.
|0 (CaQQLa)000260397
|
650 |
|
6 |
|a Immunoth�erapie.
|0 (CaQQLa)201-0067406
|
650 |
|
7 |
|a Immunotherapy
|2 fast
|0 (OCoLC)fst00968044
|
650 |
|
7 |
|a Cancer
|x Immunotherapy
|2 fast
|0 (OCoLC)fst00845386
|
650 |
|
7 |
|a Drug delivery systems
|2 fast
|0 (OCoLC)fst00898667
|
700 |
1 |
|
|a Amiji, Mansoor M.
|
700 |
1 |
|
|a Milane, Lara Scheherazade.
|
776 |
0 |
8 |
|i Print version:
|t Engineering technologies and clinical translation. Volume 3, Delivery strategies and engineering technologies in cancer immunotherapy.
|d London : Academic Press, 2022
|z 0323909493
|z 9780323909495
|w (OCoLC)1237630841
|
776 |
0 |
8 |
|i Print version:
|t Engineering technologies and clinical translation. Volume 3, Delivery strategies and engineering technologies in cancer immunotherapy
|z 9780323909495
|w (OCoLC)1263803319
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323909495
|z Texto completo
|